Close
New

Medscape is available in 5 Language Editions – Choose your Edition here.

 

Retinopathy of Prematurity Differential Diagnoses

  • Author: KN Siva Subramanian, MD; Chief Editor: Ted Rosenkrantz, MD  more...
 
Updated: Mar 01, 2015
 
 

Differential Diagnoses

  • Familial exudative vitreoretinopathy

 
 
Contributor Information and Disclosures
Author

KN Siva Subramanian, MD Professor of Pediatrics and Obstetrics/Gynecology, Chief of Neonatal Perinatal Medicine, Hospital Ethicist, Medstar Georgetown University Hospital

KN Siva Subramanian, MD is a member of the following medical societies: American Academy of Pediatrics, American Association for the Advancement of Science, American Society for Parenteral and Enteral Nutrition, New York Academy of Sciences, American College of Nutrition, American Society of Law, Medicine & Ethics, Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Coauthor(s)

Monisha Bahri, MBBS, MD Attending Physician, Department of Neonatalogy, Washington Hospital Center

Monisha Bahri, MBBS, MD is a member of the following medical societies: American Academy of Pediatrics, Medical Council of India, Indian Academy of Pediatrics

Disclosure: Nothing to disclose.

Gonzalo (Vike) Vicente, MD, FAAP Consulting Ophthalmologist, Eye Doctors of Washington

Gonzalo (Vike) Vicente, MD, FAAP is a member of the following medical societies: American Academy of Ophthalmology, American Academy of Pediatrics, American Association for Pediatric Ophthalmology and Strabismus, American Medical Association

Disclosure: Nothing to disclose.

Specialty Editor Board

Mary L Windle, PharmD Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Arun K Pramanik, MD, MBBS Professor of Pediatrics, Louisiana State University Health Sciences Center

Arun K Pramanik, MD, MBBS is a member of the following medical societies: American Academy of Pediatrics, American Thoracic Society, National Perinatal Association, Southern Society for Pediatric Research

Disclosure: Nothing to disclose.

Chief Editor

Ted Rosenkrantz, MD Professor, Departments of Pediatrics and Obstetrics/Gynecology, Division of Neonatal-Perinatal Medicine, University of Connecticut School of Medicine

Ted Rosenkrantz, MD is a member of the following medical societies: American Academy of Pediatrics, American Pediatric Society, Eastern Society for Pediatric Research, American Medical Association, Connecticut State Medical Society, Society for Pediatric Research

Disclosure: Nothing to disclose.

Additional Contributors

Oussama Itani, MD, FAAP, FACN Clinical Associate Professor of Pediatrics and Human Development, Michigan State University; Medical Director, Department of Neonatology, Borgess Medical Center

Oussama Itani, MD, FAAP, FACN is a member of the following medical societies: American Academy of Pediatrics, American Association for Physician Leadership, American Heart Association, American College of Nutrition

Disclosure: Nothing to disclose.

References
  1. Lundgren P, Stoltz Sjostrom E, Domellof M, et al. WINROP identifies severe retinopathy of prematurity at an early stage in a nation-based cohort of extremely preterm infants. PLoS One. 2013 Sep 12. 8(9):e73256. [Medline]. [Full Text].

  2. Anuk Ince D, Gülcan H, Hanta D, Ecevit A, Akkoyun I, Kurt A, et al. Poor postnatal weight gain predicts stage 3+ retinopathy of prematurity in very low birth weight infants. Turk J Pediatr. 2013 May-Jun. 55(3):304-8. [Medline].

  3. Dhaliwal CA, Fleck BW, Wright E, Graham C, McIntosh N. Retinopathy of prematurity in small-for-gestational age infants compared with those of appropriate size for gestational age. Arch Dis Child Fetal Neonatal Ed. 2009 May. 94(3):F193-5. [Medline].

  4. Hussain N, Clive J, Bhandari V. Current incidence of retinopathy of prematurity, 1989-1997. Pediatrics. 1999 Sep. 104(3):e26. [Medline]. [Full Text].

  5. STOP-ROP. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity, a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000 Feb. 105(2):295-310. [Medline].

  6. Kim TI, Sohn J, Pi SY, Yoon YH. Postnatal risk factors of retinopathy of prematurity. Paediatr Perinat Epidemiol. 2004 Mar. 18(2):130-4. [Medline].

  7. Shah VA, Yeo CL, Ling YL, Ho LY. Incidence, risk factors of retinopathy of prematurity among very low birth weight infants in Singapore. Ann Acad Med Singapore. 2005 Mar. 34(2):169-78. [Medline].

  8. Gilbert C, Fielder A, Gordillo L, et al. Characteristics of infants with severe retinopathy of prematurity in countries with low, moderate, and high levels of development: implications for screening programs. Pediatrics. 2005 May. 115(5):e518-25. [Medline].

  9. Repka MX, Summers CG, Palmer EA, et al. The incidence of ophthalmologic interventions in children with birth weights less than 1251 grams. Results through 5 1/2 years. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1998 Sep. 105(9):1621-7. [Medline].

  10. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter Trial of Cryotherapy for Retinopathy of Prematurity: ophthalmological outcomes at 10 years. Arch Ophthalmol. 2001 Aug. 119(8):1110-8. [Medline].

  11. Tadesse M, Dhanireddy R, Mittal M, Higgins RD. Race, Candida sepsis, and retinopathy of prematurity. Biol Neonate. 2002. 81(2):86-90. [Medline].

  12. Bizzarro MJ, Hussain N, Jonsson B, et al. Genetic susceptibility to retinopathy of prematurity. Pediatrics. 2006 Nov. 118(5):1858-63. [Medline].

  13. Hellstrom A, Hard AL, Engstrom E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009 Apr. 123(4):e638-45. [Medline].

  14. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005 Jul. 123(7):991-9. [Medline].

  15. [Guideline] AAP, AAO, and AAPOS. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006 Feb. 117(2):572-6. [Medline].

  16. Subhani M, Combs A, Weber P, et al. Screening guidelines for retinopathy of prematurity: the need for revision in extremely low birth weight infants. Pediatrics. 2001 Apr. 107(4):656-9. [Medline].

  17. Mintz-Hittner HA, Kuffel RR Jr. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II. Retina. 2008 Jun. 28(6):831-8. [Medline].

  18. Chen J, Smith LE. Retinopathy of prematurity. Angiogenesis. 2007. 10(2):133-40. [Medline].

  19. Connor KM, SanGiovanni JP, Lofqvist C, Aderman CM, Chen J, Higuchi A, et al. Increased dietary intake of omega-3-polyunsaturated fatty acids reduces pathological retinal angiogenesis. Nat Med. 2007 Jul. 13(7):868-73. [Medline].

  20. Mantagos IS, Vanderveen DK, Smith LE. Emerging treatments for retinopathy of prematurity. Semin Ophthalmol. 2009 Mar-Apr. 24(2):82-6. [Medline].

  21. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011 Feb 17. 364(7):603-15. [Medline].

  22. Stoltz Sjostrom E, Lundgren P, Ohlund I, et al. Low energy intake during the first 4 weeks of life increases the risk for severe retinopathy of prematurity in extremely preterm infants. Arch Dis Child Fetal Neonatal Ed. 2015 Feb 12. [Medline].

  23. Shalev B, Farr AK, Repka MX. Randomized comparison of diode laser photocoagulation versus cryotherapy for threshold retinopathy of prematurity: seven-year outcome. Am J Ophthalmol. 2001 Jul. 132(1):76-80. [Medline].

  24. Nicoara SD, Cristian C, Irimescu I, Stefanut AC, Zaharie G. Diode Laser Photocoagulation for Retinopathy of Prematurity: Outcomes After 7 Years of Treatment. J Pediatr Ophthalmol Strabismus. 2013 Nov 19. 1-7. [Medline].

  25. VanderVeen DK, Coats DK, Dobson V, et al. Prevalence and course of strabismus in the first year of life for infants with prethreshold retinopathy of prematurity: findings from the Early Treatment for Retinopathy of Prematurity study. Arch Ophthalmol. 2006 Jun. 124(6):766-73. [Medline].

  26. Good WV, Hardy RJ, Dobson V, et al. The incidence and course of retinopathy of prematurity: findings from the earlytreatment for retinopathy of prematurity study. Pediatrics. 2005 Jul. 116(1):15-23. [Medline].

  27. Console V, Gagliardi L, De Giorgi A, De Ponti E. Retinopathy of prematurity and antenatal corticosteroids. The Italian ROP Study Group. Acta Biomed Ateneo Parmense. 1997. 68 Suppl 1:75-9. [Medline].

  28. Wright KW, Sami D, Thompson L, Ramanathan R, Joseph R, Farzavandi S. A physiologic reduced oxygen protocol decreases the incidence of threshold retinopathy of prematurity. Trans Am Ophthalmol Soc. 2006. 104:78-84. [Medline].

  29. Wallace DK. Oxygen saturation levels and retinopathy of prematurity--are we on target?. J AAPOS. 2006 Oct. 10(5):382-3. [Medline].

  30. [Guideline] AAP, AAPOS, AAO. Screening examination of premature infants for retinopathy of prematurity. A joint statement of the American Academy of Pediatrics, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Pediatrics. 1997 Aug. 100(2 Pt 1):273. [Medline]. [Full Text].

  31. Bremer DL, Palmer EA, Fellows RR, et al. Strabismus in premature infants in the first year of life. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1998 Mar. 116(3):329-33. [Medline].

  32. Brooks SE, Marcus DM, Gillis D, et al. The effect of blood transfusion protocol on retinopathy of prematurity: A prospective, randomized study. Pediatrics. 1999 Sep. 104(3 Pt 1):514-8. [Medline].

  33. Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984 Aug. 102(8):1130-4. [Medline].

  34. Connolly BP, McNamara JA, Sharma S, et al. A comparison of laser photocoagulation with trans-scleral cryotherapy in the treatment of threshold retinopathy of prematurity. Ophthalmology. 1998 Sep. 105(9):1628-31. [Medline].

  35. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity: preliminary results. Pediatrics. 1988 May. 81(5):697-706. [Medline].

  36. Dani C, Reali MF, Bertini G, et al. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev. 2001 Apr. 62(1):57-63. [Medline].

  37. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003 Dec. 121(12):1684-94. [Medline].

  38. Gelman R, Martinez-Perez ME, Vanderveen DK, Moskowitz A, Fulton AB. Diagnosis of plus disease in retinopathy of prematurity using Retinal Image multiScale Analysis. Invest Ophthalmol Vis Sci. 2005 Dec. 46(12):4734-8. [Medline].

  39. Good WV. The Early Treatment for Retinopathy Of Prematurity Study: structural findings at age 2 years. Br J Ophthalmol. 2006 Nov. 90(11):1378-82. [Medline].

  40. Higgins RD, Mendelsohn AL, DeFeo MJ, et al. Antenatal dexamethasone and decreased severity of retinopathy of prematurity. Arch Ophthalmol. 1998 May. 116(5):601-5. [Medline].

  41. Hunter DG, Repka MX. Diode laser photocoagulation for threshold retinopathy of prematurity. A randomized study. Ophthalmology. 1993 Feb. 100(2):238-44. [Medline].

  42. Johnson L, Quinn GE, Abbasi S, et al. Severe retinopathy of prematurity in infants with birth weights less than 1250 grams: incidence and outcome of treatment with pharmacologic serum levels of vitamin E in addition to cryotherapy from 1985 to 1991. J Pediatr. 1995 Oct. 127(4):632-9. [Medline].

  43. Kennedy JE, Todd DA, John E. Progress in Retinopathy of Prematurity. Premature Birth and Retinopathy of Prematurity. 1997. 73-5.

  44. Lee SK, Normand C, McMillan D, et al. Evidence for changing guidelines for routine screening for retinopathy of prematurity. Arch Pediatr Adolesc Med. 2001 Mar. 155(3):387-95. [Medline].

  45. McNamara JA, Tasman W, Brown GC, Federman JL. Laser photocoagulation for stage 3+ retinopathy of prematurity. Ophthalmology. 1991 May. 98(5):576-80. [Medline].

  46. O'Keefe M, O'Reilly J, Lanigan B. Longer-term visual outcome of eyes with retinopathy of prematurity treated with cryotherapy or diode laser. Br J Ophthalmol. 1998 Nov. 82(11):1246-8. [Medline]. [Full Text].

  47. Palmer EA, Hardy RJ, Dobson V, et al. 15-year outcomes following threshold retinopathy of prematurity: final resultsfrom the multicenter trial of cryotherapy for retinopathy of prematurity. Arch Ophthalmol. 2005 Mar. 123(3):311-8. [Medline].

  48. Pearce IA, Pennie FC, Gannon LM, et al. Three year visual outcome for treated stage 3 retinopathy of prematurity: cryotherapy versus laser. Br J Ophthalmol. 1998 Nov. 82(11):1254-9. [Medline].

  49. Phelps DL. Retinopathy of prematurity. Pediatr Rev. 1995 Feb. 16(2):50-6. [Medline].

  50. Quinn GE, Dobson V, Kivlin J, et al. Prevalence of myopia between 3 months and 5 1/2 years in preterm infants with and without retinopathy of prematurity. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1998 Jul. 105(7):1292-300. [Medline].

  51. Raju TN, Langenberg P, Bhutani V, Quinn GE. Vitamin E prophylaxis to reduce retinopathy of prematurity: a reappraisal of published trials. J Pediatr. 1997 Dec. 131(6):844-50. [Medline].

  52. Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group [see comments]. N Engl J Med. 1998 May 28. 338(22):1572-6. [Medline].

  53. Saunders RA, Donahue ML, Christmann LM, et al. Racial variation in retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Arch Ophthalmol. 1997 May. 115(5):604-8. [Medline].

  54. Travassos A, Teixeira S, Ferreira P, et al. Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity. Ophthalmic Surg Lasers Imaging. 2007 May-Jun. 38(3):233-7. [Medline].

  55. Vanderveen DK, Mansfield TA, Eichenwald EC. Lower oxygen saturation alarm limits decrease the severity of retinopathy of prematurity. J AAPOS. 2006 Oct. 10(5):445-8. [Medline].

  56. Wallace DK. Oxygen saturation levels and retinopathy of prematurity--are we on target?. J AAPOS. 2006 Oct. 10(5):382-3. [Medline].

  57. Young TL, Anthony DC, Pierce E, et al. Histopathology and vascular endothelial growth factor in untreated and diode laser-treated retinopathy of prematurity. J AAPOS. 1997 Jun. 1(2):105-10. [Medline].

Previous
Next
 
Stage I retinopathy of prematurity.
Scheme of retina of right eye (RE) and left eye (LE) showing zone borders and clock hours used to describe location and extent of retinopathy of prematurity.
Zone I retinopathy of prematurity.
Zone II retinopathy of prematurity.
Zone III retinopathy of prematurity.
Stage II retinopathy of prematurity.
Stage III retinopathy of prematurity.
Retinopathy of prematurity.
Retinopathy of prematurity.
Retinopathy of prematurity.
Retinopathy of prematurity.
Retinopathy of prematurity threshold, according to the Cryotherapy for Retinopathy of Prematurity (CRYO-ROP) cooperative group.
Treatment guidelines, according to the Early Treatment for Retinopathy of Prematurity (ET-ROP) study.
Laser photocoagulation.
Cryotherapy probe application.
Table. Timing of First Eye Examination Based on Gestational Age at Birth
Gestational Age at Birth (wk)Chronologic Age (wk)Postmenstrual Age (wk)
22 *931
23 *831
24731
25631
26531
27431
28432
29433
30434
31 (if necessary)435
32 (if necessary)436
Previous
Next
 
 
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.